Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types
H. van der Wijngaart, L.R. Hoes, J.M.V. Henegouwen, D.L. van der Velden, L.J. Zeverijn, P. Roepman, E. van Werkhoven, W.W.J. de Leng, A.M.L. Jansen, N. Mehra, D.G.J. Robbrecht, M. Labots, D.J.A. de Groot, A. Hoeben, P. Hamberg, H. Gelderblom, E.E. Voest, H.M.W. Verheul*
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types'. Together they form a unique fingerprint.